Except for GPX4 (Figure 3C) and HMGCS1 (Figure 3G), the results were consistent with the expression levels in cancer tissues and normal colorectal tissues, as the expression levels decreased with the deterioration of clinicopathological conditions in patients with colorectal cancer (Figure 3). Here, GPX4 is linked to colorectal cancer.